Srinagar: At a time when doctors in Jammu and Kashmir (JK) have been asked to write generic drugs, Doctors Association Kashmir (DAK) today said that these drugs would help to reduce deaths among cancer patients.
Welcoming the move, President DAK Dr Nisar ul Hassan in a statement said research has shown that inexpensive generic drugs significantly decrease mortality among cancer patients.
Two studies published in the Lancet medical Journal found that the use of two inexpensive generic drugs – aromatase inhibitors and Bisphosphonates – significantly improved survival rates in postmenopausal women with breast cancer.
Generic drugs make treatment affordable for cancer patients and, as a result, save lives.
With the introduction of generic form of Gleevec, the drug used for chronic myeloid leukemia, many lives were saved.
Majority of cancer patients die for want of treatment because they cannot afford costly branded drugs.
Use of generic drugs in other chronic medical conditions, like diabetes, hypertension and other cardiovascular ailments would result in long term adherence to essential therapies.
While generic drugs account for 88% of prescriptions in United States, in JK, doctors prescribe more expensive brand-name drugs when equally effective and cheaper generic versions are available.
This is because of a deep rooted nexus between drug mafia and some doctors who are adopting every conceivable method to scuttle the move.
And todays government report of this nexus vindicates our stand.
This doctor-drug mafia is misleading public by spreading false information regarding generic drugs.
Generic drugs are those drugs that have gone off the patent protection and are the same as that of their branded counterparts in terms of quality and safety.
In order to have rapid access to cheaper supply of generic drugs, United Nations in its report has recommended that poorer countries should be allowed to override pharmaceuticals patents.
Be Part of Quality Journalism
Quality journalism takes a lot of time, money and hard work to produce and despite all the hardships we still do it. Our reporters and editors are working overtime in Kashmir and beyond to cover what you care about, break big stories, and expose injustices that can change lives. Today more people are reading Kashmir Observer than ever, but only a handful are paying while advertising revenues are falling fast.